AGE-RELATED MACULAR DEGENERATION (AMD)
Age-related Macular Degeneration (AMD) affects the central part of the retina (macula), leading to difficulty in reading, recognizing faces, and seeing fine details. Early diagnosis and the right injection choice are crucial to protect vision.
Types of AMD
- Dry AMD: Slow degeneration of the macula
- Wet AMD: Abnormal blood vessels causing rapid vision loss (requires injections)
Which Injection Should You Choose for AMD?
We help patients choose the most suitable injection based on effectiveness, affordability, and individual clinical need.
Most Common Injection Options
- Eylea / Eylea HD (Aflibercept): Long duration, high efficacy
- Ranibizumab (Accentrix / Lucentis): Excellent safety profile
- Faricimab (Vabysmo): Dual-action with extended injection intervals
- Bevacizumab (Avastin): Cost-effective option
How We Help You Choose
- Based on OCT and angiography findings
- Patient affordability and medicine availability
- Response to previous injections
- Honest recommendations – no unnecessary choices
Our AMD Services
- Detailed macular evaluation
- OCT and retinal imaging
- Injection therapy in operation theatre
- Post-injection monitoring
- Nutrition and lifestyle counselling
FAQs – Intravitreal Injections
Anti-VEGF / Steroid injections for Retina Diseases
1. What is an intravitreal injection?
It is a procedure where a small dose of medicine is injected inside the eye to treat retinal diseases such as DME, AMD, retinal vein occlusion, myopic CNVM, and post-surgery swelling.
2. How effective are intravitreal injections?
Anti-VEGF injections reduce retinal swelling, control abnormal blood vessels, stabilize or improve vision, and prevent further damage. Many patients notice improvement within days to weeks.
3. Do injections cure the disease permanently?
Most retinal diseases are chronic. Injections control the disease, prevent worsening, and reduce the risk of blindness, but repeated injections may be needed over time.
4. How many injections will I need?
The number depends on the disease and response: AMD usually requires at least 3 loading doses followed by monthly or treat-and-extend schedules. Your retina specialist tailors the plan using OCT scans.
5. Are intravitreal injections safe?
Yes. They are among the most commonly performed eye procedures worldwide. Injections are done under strict sterile conditions in the operating room. Serious complications are very rare.
6. What are the possible risks?
Rare risks include infection, increased eye pressure, small surface bleeding, temporary floaters, or irritation. All precautions are taken to minimize these risks.
7. Does the injection hurt?
Most patients feel mild pressure or a slight pinch. Numbing drops ensure the procedure is comfortable.
8. Is there a difference between injections?
Yes. Differences are in duration of effect, cost, and patient response. The doctor recommends the safest and most effective option for you.
9. Why are repeated injections needed?
The effect wears off in 4–8 weeks. Skipping injections can lead to disease reactivation and permanent vision loss.
10. What should I expect after the injection?
Mild redness, irritation, watering, or floaters are normal. Severe pain, vision loss, or discharge require immediate consultation.
11. Can I go home the same day?
Yes. The procedure takes only a few minutes and is done as day care.
12. Are there activity restrictions?
Avoid rubbing the eye, water entry, makeup, and heavy activity for 24–48 hours. Normal activities can resume the next day.
13. Are injections done in both eyes?
Yes, if required. They may be done on the same day or a few days apart.
14. Is long-term injection therapy safe?
Yes. Millions of patients receive repeated injections safely with regular monitoring.
15. What happens if injections are stopped?
Stopping injections without medical advice can cause rapid worsening and permanent vision loss in diseases like AMD and DME.
16. How do doctors decide when to stop?
Decisions are based on OCT findings, vision stability, absence of leakage, and treat-and-extend protocols.
17. What is “Treat and Extend”?
A modern approach where injection intervals are gradually extended once the retina stabilizes, reducing injection burden while maintaining disease control.
18. Which injection is best for me?
The choice depends on disease type, OCT findings, prior response, cost, and safety. At Rana Eye Centre, recommendations are honest, personalized, and focused on the best visual outcome.